Plus Therapeutics, Inc. (PSTV)
USD 1.0
(-6.54%)
USD 1.0
(-6.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.85 Million | -12.97 Million | -10.28 Million | -8.43 Million | -5.9 Million | -11.97 Million |
| Net Income | -13.31 Million | -20.27 Million | -13.39 Million | -8.24 Million | -10.88 Million | -12.63 Million |
| Depreciation & Amortization | 745 Thousand | 619 Thousand | 395 Thousand | 366 Thousand | 896 Thousand | 2 Million |
| Deferred income taxes | -5.73 Million | - | 60 Thousand | -2.29 Million | 3.1 Million | -1.71 Million |
| Stock-based compensation | 569 Thousand | 606 Thousand | 606 Thousand | 247 Thousand | 127 Thousand | 355 Thousand |
| Change in working capital | -1.11 Million | 5.59 Million | 1.23 Million | 119 Thousand | -938 Thousand | -1.03 Million |
| Other non-cash items | 6 Million | 481 Thousand | 820 Thousand | 1.36 Million | 1.79 Million | 1.04 Million |
| Investing Cash Flow | -160 Thousand | -759 Thousand | -82 Thousand | -493 Thousand | 5.57 Million | -133 Thousand |
| Investments in PPE | -160 Thousand | -509 Thousand | -144 Thousand | -493 Thousand | -67 Thousand | -133 Thousand |
| Acquisitions | - | -250 Thousand | 62 Thousand | -400 Thousand | 5.63 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -250 Thousand | 62 Thousand | 400 Thousand | 5.63 Million | - |
| Financing Cash Flow | 3.44 Million | 13.45 Million | 20.41 Million | -319 Thousand | 12.63 Million | 7.16 Million |
| Debt repayment | -1.6 Million | -1.6 Million | -276 Thousand | -5.42 Million | -3.82 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -474 Thousand | - | - | - | - | -1.53 Million |
| Common Stock Issuance | 5.52 Million | 15.05 Million | 18.67 Million | 4 Million | 15.96 Million | 7.23 Million |
| Other Financing Activities | 348 Thousand | -773 Thousand | 2.01 Million | 1.09 Million | 490 Thousand | 7.16 Million |
| Accounts receivables | - | - | - | 1.16 Million | -1.2 Million | -173 Thousand |
| Accounts payables | -3.67 Million | 6.45 Million | 1.73 Million | -1.23 Million | -23 Thousand | -1.42 Million |
| Inventory | - | - | - | 107 Thousand | 259 Thousand | 475 Thousand |
| Other working capital | 2.56 Million | -855 Thousand | -496 Thousand | 77 Thousand | 29 Thousand | 90 Thousand |
| Cash at beginning of period | 18.12 Million | 18.4 Million | 8.34 Million | 17.59 Million | 5.3 Million | 10.22 Million |
| Cash at end of period | 8.55 Million | 18.12 Million | 18.4 Million | 8.34 Million | 17.59 Million | 5.3 Million |
| Capital Expenditure | -160 Thousand | -509 Thousand | -144 Thousand | -493 Thousand | -67 Thousand | -133 Thousand |
| Effect of forex changes on cash | - | - | - | - | -4000.00 | 16 Thousand |
| Net cash flow / Change in cash | -9.56 Million | -280 Thousand | 10.05 Million | -9.24 Million | 12.29 Million | -4.92 Million |
| Free Cash Flow | -13.01 Million | -13.48 Million | -10.42 Million | -8.92 Million | -5.97 Million | -12.1 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.94 Million | -3.26 Million | -13.31 Million | -3.81 Million | -3.21 Million | -1.48 Million |
| Depreciation & Amortization | 202 Thousand | 186 Thousand | 745 Thousand | 182 Thousand | 245 Thousand | 131 Thousand |
| Deferred income taxes | - | - | -5.73 Million | -121 Thousand | - | - |
| Stock-based compensation | 151 Thousand | 146 Thousand | 569 Thousand | 141 Thousand | 148 Thousand | 140 Thousand |
| Change in working capital | 2.6 Million | -1.6 Million | -1.11 Million | 1.57 Million | 368 Thousand | -1.67 Million |
| Other non-cash items | -1.01 Million | 578 Thousand | 6 Million | 151 Thousand | 59 Thousand | 110 Thousand |
| Investing Cash Flow | -3.8 Million | -364 Thousand | -160 Thousand | -42 Thousand | -10 Thousand | -11 Thousand |
| Investments in PPE | -626 Thousand | -40 Thousand | -160 Thousand | -42 Thousand | -10 Thousand | -11 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -3.17 Million | -324 Thousand | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -3.72 Million | -324 Thousand | - | - | - | - |
| Financing Cash Flow | 6.96 Million | -776 Thousand | 3.44 Million | -529 Thousand | 2.52 Million | 961 Thousand |
| Debt repayment | -302 Thousand | -402 Thousand | -1.6 Million | -402 Thousand | -402 Thousand | -402 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -374 Thousand | -474 Thousand | -474 Thousand | - | - |
| Common Stock Issuance | 7.26 Million | - | 5.52 Million | 347 Thousand | 2.92 Million | 1.36 Million |
| Other Financing Activities | 10.55 Million | - | 348 Thousand | -1000.00 | 2.52 Million | 961 Thousand |
| Accounts receivables | - | - | - | 91 Thousand | -809 Thousand | 747 Thousand |
| Accounts payables | 403 Thousand | -43 Thousand | -3.67 Million | 384 Thousand | -472 Thousand | 50 Thousand |
| Inventory | - | - | - | -91 Thousand | - | -797 Thousand |
| Other working capital | 2.2 Million | -1.55 Million | 2.56 Million | 1.19 Million | 1.64 Million | -1.67 Million |
| Cash at beginning of period | 2.9 Million | 8.55 Million | 18.12 Million | 11 Million | 10.89 Million | 12.72 Million |
| Cash at end of period | 4.91 Million | 2.9 Million | 8.55 Million | 8.55 Million | 11 Million | 10.89 Million |
| Capital Expenditure | -626 Thousand | -40 Thousand | -160 Thousand | -42 Thousand | -10 Thousand | -11 Thousand |
| Effect of forex changes on cash | - | - | - | - | 37 Thousand | 1.96 Million |
| Net cash flow / Change in cash | 2.01 Million | -5.65 Million | -9.56 Million | -2.45 Million | 111 Thousand | -1.82 Million |
| Free Cash Flow | -1.77 Million | -4.55 Million | -13.01 Million | -1.92 Million | -2.4 Million | -2.78 Million |
C-PN
CG
NXLLF
YPSN
DYNAVSN
AM7